Biotechnology at CUNY Graduate School and University Center

A biotechnology bachelor's in New York City sounds promising, but the sparse data here tells its own story. With too few graduates to report outcomes, this program operates on a scale that makes it difficult to assess its actual track record. The estimated figures—$47,000 first-year earnings and $20,400 in debt—come from national benchmarks for similar biotechnology programs, not from this institution's actual results.

Those national estimates suggest a manageable debt burden at roughly 43% of first-year earnings, which is reasonable for a STEM field. However, New York biotechnology programs typically show wide variation in outcomes. Programs at Syracuse and RIT, for instance, produce similar earnings in the low-to-mid $40,000s, which aligns with the statewide median of $43,000. The national estimate of $47,000 may actually be optimistic for New York graduates. The estimated debt figure of $20,400 also sits notably below the state median of $25,500, though without actual data from this program, that advantage remains theoretical.

The real caution here is the program's small size combined with limited outcome transparency. CUNY's Graduate School is primarily known for doctoral programs, not undergraduate biotechnology degrees. Before committing, verify whether this program has robust industry connections in New York's competitive biotech sector and whether it can demonstrate actual placement success, even if the numbers aren't publicly reported.